Ken Griffin Edap Tms Sa Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$2.55 - $5.3 $71,145 - $147,870	27,900 Added 155.0%	45,900 $117,000
Q2 2024 Aug 14, 2024	SELL	$5.17 - $8.5 $137,005 - $225,250	-26,500 Reduced 59.55%	18,000 $97,000
Q1 2024 May 15, 2024	BUY	$5.1 - $7.78 $186,150 - $283,970	36,500 Added 456.25%	44,500 $327,000
Q4 2023 Feb 14, 2024	SELL	$4.15 - $7.2 $8,715 - $15,120	-2,100 Reduced 20.79%	8,000 $42,000
Q3 2023 Nov 14, 2023	SELL	$6.2 - $9.34 $71,920 - $108,344	-11,600 Reduced 53.46%	10,100 $70,000
Q2 2023 Aug 14, 2023	BUY	$8.76 - $11.92 $75,336 - $102,512	8,600 Added 65.65%	21,700 $200,000
Q1 2023 May 15, 2023	BUY	$10.44 - $12.49 $8,352 - $9,992	800 Added 6.5%	13,100 $145,000
Q4 2022 Feb 14, 2023	SELL	$8.01 - $11.35 $179,424 - $254,240	-22,400 Reduced 64.55%	12,300 $131,000
Q3 2022 Nov 14, 2022	BUY	$6.25 - $8.94 $113,750 - $162,708	18,200 Added 110.3%	34,700 $286,000

15.6M

67.6K

60.9K

Ticker EDAP
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,145,300
Market Cap $85.3M
Description
EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWav...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.